Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

147 results about "Nystatin" patented technology

This medication is used to treat fungal infections of the mouth or intestines.

Compsns-and methods for trapping and inactivating pathogenic microbes and spermatozoa

Antimicrobial and contraceptive compositions and methods which prevent and/or reduce the risk of transmission of sexually transmitted diseases through sexual activity as well as prevent and/or reduce the risk of pregnancy are provided. The compositions contain (1) a matrix-forming agent, (2) a bio-adhesive agent, (3) a buffering agent, (4) optionally a humectant, (5) optionally a preservative, and (6) water; wherein the composition is suitable for application within the vagina; wherein the compositions form a semisolid matrix on contact with ejaculate (thereby trapping ejaculated microbes and spermatozoa); wherein the composition causes hardening of cervical mucus (thereby decreasing the probability of sperm entry); wherein the composition forms a bio-adhesive layer over vaginal surfaces (thereby preventing or reducing the risk of contact of STD-causing microbes with the vaginal surfaces); wherein the composition maintains an acidic vaginal pH of less than about 5 in the presence of semen ejaculated from the male; and wherein the composition does not significantly impair the natural microbiological balance within the vagina. The antimicrobial and contraceptive compositions may also contain additional antimicrobial and/or contraceptive agents (e.g., nonoxynol-9, octoxynol-9, benzalkonium chloride, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H2SO4-modified mandelic acids, povidone iodine, itraconazole, ketoconazole, metronidazole, clotrimazole, fluconazole, teraconazole, miconazole, tinidazole, iconazole, chloramphenicol, nystatin, cyclopiroxolamine, and the like).
Owner:RUSH UNIV MEDICAL CENT

Microbial feed additive for treating piglet yellow and white dysentery and preparation method thereof

The invention discloses a microbial feed additive for treating piglet yellow and white dysentery and a preparation method thereof. The additive is prepared from the main components of bacillus subtilis and saccharomyces cerevisiae which are mixed with baking soda, xylo-oligosaccharides, vitamins, vitamin complex, glucose and the like according to certain proportions. The microbial feed additive has the following advantages that: the active substances such as subtilin, polymyxin, nystatin, gramicidin and the like generated in the growing process of the bacillus subtilis have obvious inhibitionto pathogens or conditioned pathogens of endogenous infection; cell wall polysaccharides of the saccharomyces cerevisiae and a great amount of nucleotides and bioactive peptides generated in the growing process of the saccharomyces cerevisiae can improve the immunity of animals, and a compound taste substance is also generated in the growing process of the saccharomyces cerevisiae to promote animal feeding; the baking soda replenishes electrolyte; the xylo-oligosaccharides selectively proliferate beneficial bacteria such as bifidobacterium and the like; the vitamins have the effects of resisting stress and replenishing nutrition; and the glucose has the effects of supplying energy and promoting healing.
Owner:HUAWEI TEHCHNOLOGIES CO LTD

Immunosuppressive Cell-Capturing Material and Immunosuppressive Cell-Capturing Column

This invention discloses an immunosuppressive cell-capturing material comprising a molded body that includes: a readily hydrolyzable condensation polymer having an amino group; a poorly hydrolyzable polymer coating the readily hydrolyzable condensation polymer; and a ligand-conjugated poorly hydrolyzable polymer coating the poorly hydrolyzable polymer, wherein the ligand is at least one selected from the group consisting of a NH2 group, a secondary amino group, a tertiary amino group, a polyamine residue, a basic cyclic polypeptide residue, an aminoglycosidic compound residue, chloroquine, primaquine, mefloquine, imiquimod, and nystatin, and wherein the content of the amino group in the molded body is 150 μmol / g or less. The invention also discloses an immunosuppressive cell-capturing column filled with the capturing material.
Owner:NAT UNIV CORP SHIGA UNIV OF MEDICAL SCI

Application of lysine as synergist for preparing antifungal drug

The invention relates to the medical technology field, and discloses an application of lysine as a synergist for preparing antifungal drugs like polyenes or echinocandins. The antifungal drugs may be amphotericin B, nystatin or caspofungin. The amount of lysine or pharmaceutically acceptable salts thereof in the antifungal drug effective concentration is 0.03-0.5mM. As shown in an experiment, the combination application of antifungal drugs like amphotericin B, nystatin and caspofungin, can also ensure the treatment effect on superficial and deep fungal infections in case of decrease of drug dose, and the combination can be used as a synergist of the antifungal drugs. The lysine, as the synergist of the antifungal drugs, can decrease the medical dosage of the antifungal drugs like polyenes or echinocandins, thereby alleviating the toxic and side effect of medicaments, effectively treating fungal infection, and having a high application value.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products